TrialBMC cancer2017

Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease.

Felix C Popp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.